Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on November 4, 2026

Nov. 4, 2026

Cytek Biosciences Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Immuneering to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 4, 2026

ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates

Indeterminate GlobeNewswire

Nov. 4, 2026

Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Larimar Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 4, 2026

Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Clover Health Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 4, 2026

PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

Indeterminate GlobeNewswire

Nov. 4, 2026

Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

PacBio Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Mineralys Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

Indeterminate GlobeNewswire

Nov. 4, 2026

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 4, 2026

electroCore Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Myriad Genetics Reports Third Quarter 2026 Financial Results; Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution Definitive Agreement to Sell Prenatal Health Business to Support Strategic Growth Initiatives

Indeterminate GlobeNewswire

Nov. 4, 2026

OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire

Nov. 4, 2026

LeMaitre Q3 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 4, 2026

Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire